Georgetown University’s School of Medicine Pushes Hormone Therapy for Minors

Conservative News DailyOctober 19, 2022

Georgetown University’s School of Medicine is teaching its students to administer puberty blockers and hormone therapy to minors, an investigation by The Spectator reveals.

Medical students were told in a 2021 pre-clinical course that the “only way to help” many transgender people is to “‘fix’ their bodies” through medical intervention. The course also falsely claimed that puberty blockers are “fully reversible.”

Georgetown University did not return a request for comment.

First year medical students at Georgetown are required to take a course on Human Sexuality, which is part of a foundational block on the reproductive system. In an iteration of this course last year, students were greeted with a guest lecture on “Transgender Health Care” by Dr. David S. Reitman. Reitman is an associate professor in the Department of Pediatrics, practices pediatric medicine at Georgetown University Hospital and runs the student health center at American University.

Presentation slides from Dr. Reitman’s lecture warned students that their patients suffering from gender dysphoria will likely attempt suicide if they do not treat them with puberty blockers, “gender-affirming hormone therapy” and surgical sex changes.

‘Transgender Health Care’ by Dr. David S. Reitman (Screenshot by The Spectator)

The slides spend a significant amount of time explaining how to identify and treat transgender children. Reitman claims that children may present signs of gender differences “as early as infancy” and suggests young children might be transgender if they express preferences for clothing, toys or hairstyles typically associated with the opposite sex.

‘Transgender Health Care’ by Dr. David S. Reitman (Screenshot by The Spectator)

Reitman suggests treating children suffering from gender dysphoria by using puberty blocking drugs, which will prevent them from developing “unwanted secondary gender/sex characteristics” — for example, breast development in females or penile and testicle growth in males. An added benefit of these drugs, Reitman notes, is that transgender individuals may no longer have to undergo surgical sex changes later on in their transition.

‘Transgender Health Care’ by Dr. David S. Reitman (Screenshot by The Spectator)

The lecture slides list several side effects of puberty blocking drugs — including adverse effects to bone density and the aforementioned lack of development of secondary sex characteristics — and admits there are few long-term studies on the potential impacts to a patient’s health. Nonetheless, Reitman still claims that